Document is current
Any future updates will be listed below
-
Authors
Hehl, Laura A.
Horn-Ghetko, Daniel https://orcid.org/0000-0003-2290-2147
Prabu, J. Rajan https://orcid.org/0000-0002-7726-9310
Vollrath, Ronnald
Vu, D. Tung https://orcid.org/0000-0002-7573-1591
Pérez Berrocal, David A.
Mulder, Monique P. C.
van der Heden van Noort, Gerbrand J.
Schulman, Brenda A.
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
EC | Horizon 2020 Framework Programme (789016-NEDD8Activate)
Deutsche Forschungsgemeinschaft (SCHU 3196/1)
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 30 July 2023
First Online: 24 August 2023
Competing interests
: B.A.S. is a member of the scientific advisory boards of Interline Therapeutics and BioTheryX and co-inventor of intellectual property licensed to Cinsano. The remaining authors declare no competing interest.
